Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study

被引：5
|
作者：
Soto, Caitlin L. [1 ]
Hsu, Alice J. [1 ]
Lee, Jae Hyoung [2 ]
Dzintars, Kathryn [1 ]
Choudhury, Rebecca [3 ]
Jenkins, Timothy C. [4 ]
Mccreary, Erin K. [5 ]
Quartuccio, Katelyn S. [6 ]
Stohs, Erica J. [7 ]
Zimmerman, Matty [1 ]
Tamma, Pranita D. [2 ,8 ]
机构：
[1] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA
[3] Montefiore Med Ctr, Dept Med, Bronx, NY USA
[4] Denver Hlth, Dept Med, Denver, CO USA
[5] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA USA
[6] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14627 USA
[7] Univ Nebraska, Dept Med, Med Ctr, Omaha, NE USA
[8] Johns Hopkins Univ, Dept Pediat, Sch Med, 200 North Wolfe St,Rubinstein Bldg,Rm 3149, Baltimore, MD 21287 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2024年 / 78卷 / 01期
关键词：
carbapenem-resistant Enterobacterales; bacteremia; ceftazidime-avibactam; meropenem-vaborbactam;
D O I：
10.1093/cid/ciad476
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7-10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14-21 days, median 14 days).
引用
收藏
页码：27 / 30
页数：4
相关论文
共 50 条
  • [1] Comparative effectiveness of antibiotic therapy for carbapenem-resistant Enterobacterales (CRE) bloodstream infections in hospitalized US veterans
    Wilson, Geneva M.
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Smith, Bridget M.
    Gonzalez, Beverly
    Jones, Makoto
    Schweizer, Marin L.
    Evans, Martin
    Evans, Charlesnika T.
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (05):
  • [2] Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study
    Zhou, Chaoe
    Jin, Longyang
    Wang, Qi
    Wang, Xiaojuan
    Chen, Fengning
    Gao, Yue
    Zhao, Chunjiang
    Chen, Hongbin
    Cao, Bin
    Wang, Hui
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 731 - 742
  • [3] Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
    Park, Se Yoon
    Baek, Yae Jee
    Kim, Jung Ho
    Seong, Hye
    Kim, Bongyoung
    Kim, Yong Chan
    Yoon, Jin Gu
    Heo, Namwoo
    Moon, Song Mi
    Kim, Young Ah
    Song, Joon Young
    Choi, Jun Yong
    Park, Yoon Soo
    INFECTION AND CHEMOTHERAPY, 2024, 56 (03): : 308 - 328
  • [4] Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales
    Chen, Liang
    Han, Xiudi
    Li, YanLi
    Li, Minghui
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [5] Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study
    Almangour, Thamer A.
    Ghonem, Leen
    Aljabri, Ahmad
    Alruwaili, Alya
    Al Musawa, Mohammed
    Damfu, Nader
    Almalki, Mesfer S.
    Alattas, Majda
    Abed, Hossam
    Naeem, Doaa
    Almalki, Nawaf
    Alhifany, Abdullah A.
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 211 - 221
  • [6] Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies
    Chen, Yi
    Huang, Jiangqing
    Dong, Luyan
    Xu, Binbin
    Li, Lei
    Zhao, Zhichang
    Li, Bin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [7] Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study
    Russo, Alessandro
    Bassetti, Matteo
    Ceccarelli, Giancarlo
    Carannante, Novella
    Losito, Angela Raffaella
    Bartoletti, Michele
    Corcione, Silvia
    Granata, Guido
    Santoro, Antonella
    Giacobbe, Daniele Roberto
    Peghin, Maddalena
    Vena, Antonio
    Amadori, Francesco
    Segala, Francesco Vladimiro
    Giannella, Maddalena
    Di Caprio, Giovanni
    Menichetti, Francesco
    Del Bono, Valerio
    Mussini, Cristina
    Petrosillo, Nicola
    De Rosa, Francesco Giuseppe
    Viale, Pierluigi
    Tumbarello, Mario
    Tascini, Carlo
    Viscoli, Claudio
    Venditti, Mario
    JOURNAL OF INFECTION, 2019, 79 (02) : 130 - 138
  • [8] Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
    Neuner, Elizabeth A.
    Yeh, Jun-Yen
    Hall, Gerri S.
    Sekeres, Jennifer
    Endimiani, Andrea
    Bonomo, Robert A.
    Shrestha, Nabin K.
    Fraser, Thomas G.
    van Duin, David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (04) : 357 - 362
  • [9] Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions
    Tompkins, Kathleen
    van Duin, David
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (10) : 2053 - 2068
  • [10] The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China
    Zou, Dongna
    Yao, Guangyue
    Shen, Chengwu
    Ji, Jinru
    Ying, Chaoqun
    Wang, Peipei
    Liu, Zhiying
    Wang, Jun
    Jin, Yan
    Xiao, Yonghong
    FRONTIERS IN MICROBIOLOGY, 2021, 12
12345